News & Events

News

March 22, 2018

Now Available From Onco360 - The New IMBRUVICA® pill is now available as a one pill, once a day treatment.

August 1, 2017

Onco360 announces selection to highly limited pharmacy network for NERLYNX.

April 14, 2016

Onco360 announces selection to highly limited pharmacy network for VENCLEXTA.

March 22, 2016

Limited distribution medication XALKORI (crizotinib) receives approval for certain NSCLC patients.

March 7, 2016

Limited distribution breast cancer medication IBRANCE approved for additional indication.

February 9, 2016

Imatinib Mesylate (generic Gleevec) was recently approved for 7 indications.

January 25, 2016

Combination therapy receives accelerated approval for new indication. OPDIVO also receives additional indication as a single therapy.

October 7, 2015

Onco360 Selected for Lonsurf Limited Distribution Pharmacy Network

June 16, 2015

Onco360 Receives URAC Specialty Pharmacy Accreditation...

February 9, 2015

Newly Approved Ibrance® (palbociclib) From Pfizer Available Through Onco360; Company Again Selected as Limited Distribution Pharmacy Provider

October 22–25, 2018

Can we talk? Schedule a meeting with Onco360 at this year’s 2018 AMCP Nexus.

November 15–18, 2018

Join us at the 9th Annual Navigation & Survivorship Conference hosted by AONN+.

December 1–4, 2018

Can we talk? Schedule a meeting with Onco360 at this year’s 2018 ASH Annual Meeting & Exposition.

December 4–8, 2018

Can we talk? Schedule a meeting with Onco360 at this year’s 2018 San Antonio Breast Cancer Symposium.